Sprint Bioscience AB
STO:SPRINT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sprint Bioscience AB
STO:SPRINT
|
SE |
|
Dollar General Corp
NYSE:DG
|
US |
|
Konami Holdings Corp
TSE:9766
|
JP |
Wall St Price Targets
SPRINT Price Targets Summary
Sprint Bioscience AB
According to Wall Street analysts, the average 1-year price target for SPRINT is 3.37 SEK with a low forecast of 3.33 SEK and a high forecast of 3.47 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPRINT's stock price target?
Price Target
3.37
SEK
According to Wall Street analysts, the average 1-year price target for SPRINT is 3.37 SEK with a low forecast of 3.33 SEK and a high forecast of 3.47 SEK.
What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%
Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.
What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%
The compound annual growth rate for Operating Income over the next 3 years is -73%.
What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-24%
The compound annual growth rate for Net Income over the next 2 years is -24%.
